Loading resource…

The George Institute for Global Health, Australia
The research presents a double-blind, randomized controlled trial involving critically ill patients assigned to receive either BMES or saline as fluid therapy in the intensive care unit. The primary outcome measured was death from any cause within 90 days after randomization, with secondary outcomes including the need for new renal-replacement therapy and changes in creatinine levels. The findings contribute to the ongoing debate regarding optimal fluid resuscitation strategies in critical care settings.
No account needed